secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVAI BIO, INC. (AVAI)
CIK:        0001740797
Form:       8-K
Filed at:   2026-02-09T23:59:59+00:00
Accession:  0001740797-26-000005
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avant Technologies renamed Avaí Bio, Inc. effective Feb 3, 2026; AVAI ticker unchanged
--------------------------------------------------------------------------------

- Certificate of Amendment filed with Nevada on Feb 3, 2026, to change corporate name to Avaí Bio, Inc.
- Trading symbol will remain AVAI; no change to stock trading or listing.
- Company is a Nevada corporation; principal address unchanged at Las Vegas, NV.
- Name change is effective as of Feb 3, 2026; no impact on shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1740797/000174079726000005/0001740797-26-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1740797/000174079726000005/avai_8k.htm
  HTML page:      https://secwatch.observer/filing/0001740797-26-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer